Insider Trading History of Arena Paul R

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Arena Paul R since 2008. The trader's CIK number is 1275657. At the time of the last reporting, Arena Paul R was the CEO & Secretary of Parallax Health Sciences, Inc.. (stock ticker symbol PRLX). Also see all insider trading activities at Parallax Health Sciences, Inc..

Note that in the past ARENA PAUL R also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at I2 Telecom International Inc (ITUI) by Arena Paul R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 ITUI 0 $0 0 $0 5,779,697 $502,833

Yearly summary of insider trading at Parallax Health Sciences, Inc. (PRLX) by Arena Paul R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 PRLX 1,600,000 $100,800 0 $0 0 $0
2019 PRLX 2,000,000 $100,000 0 $0 0 $0
2018 PRLX 2,500,000 $2,500 0 $0 0 $0


Insider trading activities at 2 companies by Arena Paul R:

1. I2 Telecom International Inc (ITUI)

2. Parallax Health Sciences, Inc. (PRLX)

Table 1. Insider trading of I2 Telecom International Inc (ITUI) by Arena Paul R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-08-12 ITUI Option Ex 5,779,697 .09 502,833

Table 2. Insider trading of Parallax Health Sciences, Inc. (PRLX) by Arena Paul R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-12-31 PRLX Buy 2,000,000 .05 100,000
2019-09-30 PRLX Buy 1,600,000 .06 100,800
2018-04-06 PRLX Buy 2,500,000 .00 2,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Arena Paul R (CEO & Secretary of Parallax Health Sciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.